From: miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase
Variable
Hazard ratio
95% CI
p value
miR-130a
0.558
0.426–0.733
2.48 ∙ 10 −5
miR-222
1.341
1.166–1.541
3.65 ∙ 10 −5
miR-221
1.416
1.187–1.690
0.0001093
miR-20a
0.693
0.560–0.857
0.0007161